Third Wave “Inevitable, Could Hit India In 6 To 8 Weeks”: AIIMS Chief
A new frontier will have to be developed in India’s fight against Covid to further study the mutation of the
Read more
Health
SputnikV to be available in 9 more cities across India
Being a limited pilot phase presently, registration on CoWIN is not open yet to members of the public. This will
Read more
‘Green Fungus’ Case Reported In Madhya Pradesh, Says Doctor, In New Worry
After tests, it was found that the Covid survivor had contracted Green Fungus – an infection that had earlier been
Read more
Any Death Or Hospitalisation After Covid Vaccination Can’t Be Automatically Linked To It: Centre
As per the official release by the ministry, there have been some media reports suggesting an increase in the cases
Read more
Black fungus declared epidemic in Jharkhand
On June 7, Union Health Minister Harsh Vardhan said 28,252 cases of black fungus had been reported from 28 states/UTs
Read more
Anyone 18+ Can Walk-In For CoWin Registration, Vaccination: Government
‘Vaccine hesitancy’, the government said last week, is “a globally accepted phenomenon and should be addressed by scientifically studying the
Read more
Delta Variant Can Infect Despite Covishield, Covaxin Doses: AIIMS Study
Data from the AIIMS and NCDC studies indicated the ‘alpha’ variant is also proving resistant to Covishield and Covaxin, but
Read more
Now mistakes will be rectified on the Cowin Portal itself: Vaccine certificates may contain corrections related to name, date of birth and gender; Know the whole process
The central government has added a new feature on the Cowin portal. With this, if any mistake has been made in
Read more
‘Doctors on Wheels’ Make Covid Healthcare Accessible For Rural India
A startup called DoctCo, the Lung Care Foundation and the Delhi Sikh Gurudwara Management Committee came together for this initiative
Read more
Vaccines for children, indemnity for India’s vaccine makers: Govt clarifies
The Centre has checked with other nations and the World Health Organization regarding Pfizer’s demand of indemnity, Niti Aayog (health)
Read more